Fluocinonide
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01047 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 30 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | alopecia mucinosa | KG + DL |
| 2 | telogen effluvium | KG + DL |
| 3 | alopecia areata | KG + DL |
| 4 | Quinquaud’s folliculitis decalvans | KG + DL |
| 5 | hereditary hypotrichosis with recurrent skin vesicles | KG + DL |
| 6 | alopecia antibody deficiency | KG + DL |
| 7 | alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome | KG + DL |
| 8 | atrichia with papular lesions | KG + DL |
| 9 | alopecia universalis onychodystrophy vitiligo | KG + DL |
| 10 | lichen planus pigmentosus | KG + DL |
| 11 | hypertrophic lichen planus | KG + DL |
| 12 | annular atrophic lichen planus | KG + DL |
| 13 | vulvar inverted follicular keratosis | KG + DL |
| 14 | lichen planus pemphigoides | KG + DL |
| 15 | 2-hydroxyethyl methacrylate sensitization | KG + DL |
| 16 | primary cutaneous B-cell lymphoma | KG + DL |
| 17 | polyp of vocal cord | KG + DL |
| 18 | polyp of middle ear | KG + DL |
| 19 | polyp of frontal sinus | KG + DL |
| 20 | polyp of external auditory canal | KG + DL |
| 21 | epulis | KG + DL |
| 22 | fibroepithelial polyp | KG + DL |
| 23 | polyp of ureter | KG + DL |
| 24 | polyp of vulva | KG + DL |
| 25 | neoplastic polyp | KG + DL |
| 26 | uterine polyp | KG + DL |
| 27 | persistent polyclonal B-cell lymphocytosis | KG + DL |
| 28 | BENTA disease | KG + DL |
| 29 | severe combined immunodeficiency due to CARD11 deficiency | KG + DL |
| 30 | miliary tuberculosis | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.